Dana Ritchie, Esq.is an attorney with Anna Longwell, P.C., a law firm specializing in food and drug law which serves its clients in assessing regulatory options, product development planning, drafting submissions, compliance programs, and joint development agreements. Before joining the law firm, Ms. Ritchie advised on intellectual property matters at Aerogen (recently acquired by Nektar), a pulmonary drug delivery technology platform (combination product) for an aminoglycoside for the treatment of respiratory infections (Ventilator Associated Pneumonia). Prior to her work at Aerogen, Ms. Ritchie practiced civil litigation. Ms. Ritchie received a Bachelor of Science in Genetics from U.C. Berkeley, and a Juris Doctorate from Southwestern University School of Law, and is a member of the California Bar. Ms. Ritchie is a member of U.C.S.F.’s Committee on Human Research (an institutional review board), she also sits on the Executive Board of Women in Licensing (a chapter of Licensing Executive Society), and the Board of Directors for STAR Programs (a non-profit organization that places children in group homes and foster care).
